Genomics Medicine Ireland Attracts ISIF Capital
Posted on 10/28/2016
Dublin-based life sciences startup Genomics Medicine Ireland raised US$ 40 million in a Series A round. Investors in the round include ARCH Venture Partners, the Ireland Strategic Investment Fund (ISIF), GV (formerly Google Ventures) and Polaris Partners. Genomics Medicine Ireland plans to use the capital proceeds to establish a genomic research and development program in […]
- Alternatives
- Amgen
- ARCH Venture
- deCODE
- Europe
- genome
- healthcare
- Iceland
- Ireland
- Ireland Strategic Investment Fund
